This week’s View covers articles about cardiovascular magnetic resonance evaluation of myocardial injury in patients with troponin-positive coronavirus disease 2019 (COVID-19), dose timing and variations in the efficacy of the ChAdOx1 nCoV-19 vaccine in reducing the risk of symptomatic COVID-19, and the 3-year outcomes of transcatheter mitral valve repair in patients with heart failure and functional mitral regurgitation.